Table 1. COVID-19 testing, incidence and epidemic phase in six European countries, weeks 13 to 30 2021.
Average tests per 1,000 population per daya | Incidence per 100,000 population per weeka | Test positivity rate (%)a | Proportion (%) of RT-PCR among all tests | Context April–July 2021b | |
---|---|---|---|---|---|
Belgium | 4.3 | 117 | 3.9 | 95 | Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period. |
England | 17.4 | 139 | 1.1 | 22 | Low incidence before fourth wave in June and July. Non-pharmaceutical interventions reduced during this period. |
France | 4.9 | 148 | 4.3 | 80 | Declining incidence at the end of the third wave until quickly rising cases in July. Non-pharmaceutical interventions reduced during this period. |
Italy | 3.8 | 75 | 2.8 | 45 | Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period. |
Romania | 1.3 | 40 | 4.3 | 50 | Declining incidence at the end of the third wave with stable low rates in July. Non-pharmaceutical interventions remained stable during this period. |
Sweden | 3.3 | 125 | 5.4 | 90 | Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period. |
a Average across the period from week 13 to week 30 2021.
b Information on non-pharmaceutical interventions represents the general situation over the study period. More detailed information is provided in the Response Measures Database published by European Centre for Disease Prevention and Control (ECDC) [19].
Source: National data, ECDC, participating country representatives, open online sources.